Astrocytoma Subependymal

In all cases where any neoplasms occur in the subcortical layer, this most often indicates serious disorders of brain function. Obviously, such a disease can lead to various consequences, including death.

Astrocytoma is a malignant tumor that develops from brain ependymal cells and is located in the lower part of the brain hemispheres directly below the ependyma. Such tumors are also called subependymal glomerular or sub

Subependymal astrocytoma: main characteristics and clinical aspects

Subependymal astrocytoma, also known as subependymoma or subependymal glomerular astrocytoma, is a rare type of brain tumor that arises from astrocytes, the cells responsible for supporting and nourishing nerve cells. This tumor occurs predominantly in children and young adults.

Subependymal astrocytoma develops in the area of ​​the subependyma, a thin layer of cells covering the inner surface of the ventricles of the brain where cerebrospinal fluid is produced. Typically, this tumor occurs in the space between the ventricles of the brain, especially in the choroid plexus.

The clinical manifestation of subependymal astrocytoma can be varied and depends on the location and size of the tumor. It can cause headaches, nausea, vomiting, blurred vision, seizures, behavioral changes, and loss of coordination. In rare cases, cystic cavities may form inside the tumor, which further complicates the clinical picture.

To diagnose subependymal astrocytoma, it is necessary to conduct a comprehensive examination, including magnetic resonance imaging (MRI) and tumor biopsy to determine its histological type. MRI allows you to visualize the tumor and determine its exact location and size.

Treatment for subependymal astrocytoma includes surgery, radiotherapy, and chemotherapy. The goal of surgery is to remove as much of the tumor as possible without damaging surrounding healthy tissue. Radiotherapy and chemotherapy are used to destroy residual tumor cells and prevent recurrence.

The prognosis of subependymal astrocytoma depends on many factors, including the patient's age, tumor stage, tumor size, and characteristics. In general, the prognosis is usually better in patients with small tumors who have successfully undergone complete tumor resection. However, even after successful treatment, regular monitoring and monitoring is necessary to detect relapse or other complications.

In conclusion, subependymal astrocytoma is a rare brain tumor that requires a comprehensive approach to diagnosis and treatment. Early diagnosis, surgery and the combined use of radiotherapy and chemotherapy help improve prognosis and survival of patients. Further research and development of new therapeutic approaches will help improve the treatment of this rare disease and improve the quality of life of patients.